Wells Fargo raised the firm’s price target on Insulet (PODD) to $360 from $350 and keeps an Overweight rating on the shares. The firm notes the company posted a strong Q3 sales/EPS beat and raised FY25 guidance by more than 2-times the beat, mainly on U.S. growth.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: